Related Experiment Video
Updated: Sep 2, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Foundation models for cardiovascular diseases and medicine
Jiancheng Ye1,2, Sophie Bronstein1, Malak Abu Hashish3
1Weill Cornell Medicine, Cornell University, New York, NY, USA.
Abstract:
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, accounting for more than 17 million deaths annually. Foundation models (FMs) are large-scale artificial intelligence systems pre-trained on broad datasets and increasingly studied for cardiovascular diagnosis, risk prediction, workflow support, and treatment personalization. This narrative review synthesizes evidence on FMs applied to cardiovascular medicine, including text-based, image-based, multimodal, and time-series models. The review examined model architectures, training strategies, performance metrics, clinical applications, implementation challenges, and evidence maturity using a three-tier framework. Cardiovascular FMs show promising but unevenly validated capabilities across multiple applications. Electrocardiogram (ECG)-based models such as ECGFounder have reported strong external validation performance for rhythm and conduction diagnoses, whereas imaging models such as Echo-Vision-FM support cardiac function assessment and pathology classification. Multimodal models, including CardioGPT and EchoCLIP, illustrate the potential value of integrating clinical text, imaging, and physiological signals, although several remain at a conceptual or proof-of-concept stage. Foundation models may become important tools in cardiovascular medicine by supporting earlier diagnosis, risk stratification, and clinical decision-making. However, the current evidence base remains heterogeneous, and major barriers persist, including limited interpretability, underrepresentation of diverse populations in training data, regulatory uncertainty, computational demands, and workflow integration challenges. Inclusive data development, transparent reporting, external validation, prospective clinical evaluation, and interdisciplinary implementation research are needed before these models can be deployed safely and equitably in routine cardiovascular care.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure I: Introduction
Coronary Artery Disease II: Pathophysiology
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

